Systemic administration of interleukin-2 inhibits inflammatory neutrophil migration: Role of nitric oxide

British Journal of Pharmacology

Volumn 148, Issue 8, 2006, Pages 1060-1066

  Moreno, Susana E ^a   Alves Filho, José C ^a   Bertozi, Giuliana ^a   Alfaya, Tais M ^a   Thèze, Jacques ^b   Ferreira, Sergio H ^a   Vargaftig, Bernardo Boris ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

^b INSTITUT PASTEUR   (France)

Author keywords

Interleukin 2; Neutrophil migration; Nitric oxide; Vascular leakage syndrome

Indexed keywords

AMINOGUANIDINE; CARRAGEENAN; CYTOKINE; FORMYLMETHIONYLLEUCYLPHENYLALANINE; INTERLEUKIN 1BETA; LIPOPOLYSACCHARIDE; NITRIC OXIDE; RECOMBINANT INTERLEUKIN 2; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL CELL; ANIMAL EXPERIMENT; ANTIBODY SPECIFICITY; ARTICLE; CAPILLARY LEAK SYNDROME; CONTROLLED STUDY; DRUG MECHANISM; HUMAN; INFECTION; INFECTION RISK; INFLAMMATION; LEUKOCYTE ACTIVATION; LEUKOCYTE ADHERENCE; LEUKOCYTE MIGRATION; LEUKOCYTE ROLLING; MEDIATOR RELEASE; MESENTERY BLOOD FLOW; MOUSE; NEUTROPHIL CHEMOTAXIS; NONHUMAN; PERITONEUM; PRIORITY JOURNAL;

ANIMALS; CARRAGEENAN; CELL MOVEMENT; INFLAMMATION; INJECTIONS, INTRAVENOUS; INTERLEUKIN-2; LIPOPOLYSACCHARIDES; LUNG; MICE; MICE, INBRED C57BL; N-FORMYLMETHIONINE LEUCYL-PHENYLALANINE; NEUTROPHILS; NITRIC OXIDE;

EID: 33747119700     PISSN: 00071188     EISSN: 14765381     Source Type: Journal    
DOI: 10.1038/sj.bjp.0706835     Document Type: Article

References (52)

1. ALVES-FILHO, J.C., BENJAMIM, C., TAVARES-MURTA, B.M. & CUNHA, F.Q. (2005). Failure of neutrophil migration toward infectious focus in severe sepsis: a critical event for the outcome of this syndrome. Mem. Inst. Oswaldo Cruz., 100 (Suppl. 1), 223-226.
2. ALVES-FILHO, J.C., DE FREITAS, A., RUSSO, M. & CUNHA, F.Q. (2006). Toll-like receptor 4 signaling leads to neutrophil migration impairment in polymicrobial sepsis. Crit. Care Med., 34, 461-470.
3. ARMSTEAD, V.E., MINCHENKO, A.G., SCHUHL, R.A., HAYWARD, R., NOSSULI, T.O. & LEFER, A.M. (1997). Regulation of P-selectin expression in human endothelial cells by nitric oxide. Am. J. Physiol., 273, H740-H746.
4. ASSIER, E., JULLIEN, V., LEFORT, J., MOREAU, J.L., DI SANTO, J.P., VARGAFTIG, B.B., LAPA E SILVA, J.R. & THEZE, J. (2004). NK cells and polymorphonuclear neutrophils are both critical for IL-2-induced pulmonary vascular leak syndrome. J. Immunol., 172, 7661-7668.
5. BALUNA, R. & VITETTA, E.S. (1997). Vascular leak syndrome: a side effect of immunotherapy. Immunopharmacology, 37, 117-132.
6. BECKNELL, B. & CALIGIURI, M.A. (2005). Interleukin-2, interleukin-15, and their roles in human natural killer cells. Adv. Immunol., 86, 209-239.
7. BENJAMIM, C.F., FERREIRA, S.H. & CUNHA, F.Q. (2000). Role of nitric oxide in the failure of neutrophil migration in sepsis. J. Infect. Dis., 182, 214-223.
8. BENJAMIM, C.F., SILVA, J.S., FORTES, Z.B., OLIVEIRA, M.A., FERREIRA, S.H. & CUNHA, F.Q. (2002). Inhibition of leukocyte rolling by nitric oxide during sepsis leads to reduced migration of active microbicidal neutrophils. Infect. Immun., 70, 3602-3610.
9. BOCK, S.N., LEE, R.E., FISHER, B., RUBIN, J.T., SCHWARTZENTRUBER, D.J., WEI, J.P., CALLENDER, D.P., YANG, J.C., LOTZE, M.T. & PIZZO, P.A. (1990). A prospective randomized trial evaluating prophylactic antibiotics to prevent triple-lumen catheter-related sepsis in patients treated with immunotherapy. J. Clin. Oncol., 8, 161-169.
10. CAREY, P.D., WAKEFIELD, C.H. & GUILLOU, P.J. (1997). Neutrophil activation, vascular leak toxicity, and cytolysis during interleukin-2 infusion in human cancer. Surgery, 122, 918-926.
11. CAVAILLON, J.M., ADIB-CONQUY, M., FITTING, C., ADRIE, C. & PAYEN, D. (2003). Cytokine cascade in sepsis. Scand. J. Infect. Dis., 35, 535-544.
12. CROSARA-ALBERTO, D.P., DARINI, A.L., INOUE, R.Y., SILVA, J.S., FERREIRA, S.H. & CUNHA, F.Q. (2002). Involvement of NO in the failure of neutrophil migration in sepsis induced by Staphylococcus aureus. Br. J. Pharmacol., 136, 645-658.
13. DAVID, D., KELLER, H., NAIT-IGHIL, L., TREILHOU, M.P., JOUSSEMET, M., DUPONT, B., GACHOT, B., MARAL, J. & THEZE, J. (2002). Involvement of Bcl-2 and IL-2R in HIV-positive patients whose CD4 cell counts fail to increase rapidly with highly active antiretroviral therapy. AIDS, 16, 1093-1101.
14. DAVID, D., NAIT-IGHIL, L., DUPONT, B., MARAL, J., GACHOT, B. & THEZE, J. (2001). Rapid effect of interleukin-2 therapy in human immunodeficiency virus-infected patients whose CD4 cell counts increase only slightly in response to combined antiretroviral treatment. J. Infect. Dis., 183, 730-735.
15. DE SANCTIS, J.B., BLANCA, I. & BIANCO, N.E. (1997). Secretion of cytokines by natural killer cells primed with interleukin-2 and stimulated with different lipoproteins. Immunology, 90, 526-533.
16. DOERSCHUK, C.M. (2000). Leukocyte trafficking in alveoli and airway passages. Respir. Res., 1, 136-140.
17. FORTES, Z.B., FARSKY, S.P., OLIVEIRA, M.A. & GARCIA-LEME, J. (1991). Direct vital microscopic study of defective leukocyte-endothelial interaction in diabetes mellitus. Diabetes, 40, 1267-1273.
18. FRAKER, D.L., LANGSTEIN, H.N. & NORTON, J.A. (1989). Passive immunization against tumor necrosis factor partially abrogates interleukin 2 toxicity. J. Exp. Med., 170, 1015-1020.
19. GAUTHIER, T.W., DAVENPECK, K.L. & LEFER, A.M. (1994). Nitric oxide attenuates leukocyte-endothelial interaction via P-selectin in splanchnic ischemia-reperfusion. Am. J. Physiol., 267, G562-G568.
20. GEBB, S.A., GRAHAM, J.A., HANGER, C.C., GODBEY, P.S., CAPEN, R.L., DOERSCHUK, C.M. & WAGNER JR., W.W. (1995). Sites of leukocyte sequestration in the pulmonary microcirculation. J. Appl. Physiol., 79, 493-497.
21. 15N]nitrate in biological fluids. Anal. Biochem., 126, 131-138.
22. HURST, S.M., WILKINSON, T.S., MCLOUGHLIN, R.M., JONES, S., HORIUCHI, S., YAMAMOTO, N., ROSE-JOHN, S., FULLER, G.M., TOPLEY, N. & JONES, S.A. (2001). Il-6 and its soluble receptor orchestrate a temporal switch in the pattern of leukocyte recruitment seen during acute inflammation. Immunity, 14, 705-714.
23. JABLONS, D., BOLTON, E., MERTINS, S., RUBIN, M., PIZZO, P., ROSENBERG, S.A. & LOTZE, M.T. (1990). IL-2-based immunotherapy alters circulating neutrophil Fc receptor expression and chemotaxis. J. Immunol., 144, 3630-3636.
24. LENTSCH, A.B., EDWARDS, M.J., SIMS, D.E. & MILLER, F.N. (1998). N omega-nitro-L-arginine methyl ester inhibits inflammatory liver injury induced by interleukin-2. J. Leukocyte Biol., 63, 22-30.
25. LENTSCH, A.B., MILLER, F.N. & EDWARDS, M.J. (1999). Mechanisms of leukocyte-mediated tissue injury induced by interleukin-2. Cancer Immunol. Immunother., 47, 243-248.
26. LOCKER, G.J., KAPIOTIS, S., VEITL, M., MADER, R.M., STOISER, B., KOFLER, J., SIEDER, A.E., RAINER, H., STEGER, G.G., MANNHALTER, C. & WAGNER, O.F. (1999). Activation of endothelium by immunotherapy with interleukin-2 in patients with malignant disorders. Br. J. Haematol., 105, 912-919.
27. LOKUTA, M.A. & HUTTENLOCHER, A. (2005). TNF-alpha promotes a stop signal that inhibits neutrophil polarization and migration via a p38 MAPK pathway. J. Leukocyte Biol., 78, 210-219.
28. LUSTER, A.D., ALON, R. & VON ANDRIAN, U.H. (2005). Immune cell migration in inflammation: present and future therapeutic targets. Nat. Immunol., 6, 1182-1190.
29. MERCER-JONES, M.A., HEINZELMANN, M., PEYTON, J.C., WICKEL, D., COOK, M. & CHEADLE, W.G. (1997). Inhibition of neutrophil migration at the site of infection increases remote organ neutrophil sequestration and injury. Shock, 8, 193-199.
30. MISKO, T.P., MOORE, W.M., KASTEN, T.P., NICKOLS, G.A., CORBETT, J.A., TILTON, R.G., MCDANIEL, M.L., WILLIAMSON, J.R. & CURRIE, M.G. (1993). Selective inhibition of the inducible nitric oxide synthase by aminoguanidine. Eur. J. Pharmacol., 233, 119-125.
31. NATARAJAN, V., LEMPICKI, R.A., SERETI, I., BADRALMAA, Y., ADELSBERGER, J.W., METCALF, J.A., PRIETO, D.A., STEVENS, R., BASELER, M.W., KOVACS, J.A. & LANE, H.C. (2002). Increased peripheral expansion of naive CD4+ T cells in vivo after IL-2 treatment of patients with HIV infection. Proc. Natl. Acad. Sci. U.S.A., 99, 10712-10717.
32. ORUCEVIC, A., HEARN, S. & LALA, P.K. (1997). The role of active inducible nitric oxide synthase expression in the pathogenesis of capillary leak syndrome resulting from interleukin-2 therapy in mice. Lab. Invest., 76, 53-65.
33. ORUCEVIC, A. & LALA, P.K. (1996a). Effects of N(G)-Nitro-L-arginine methyl ester, an inhibitor of nitric oxide synthesis, on IL-2-induced LAK cell generation in vivo and in vitro in healthy and tumor-bearing mice. Cell Immunol., 169, 125-132.
34. ORUCEVIC, A. & LALA, P.K. (1996b). NG-nitro-L-arginine methyl ester, an inhibitor of nitric oxide synthesis, ameliorates interleukin 2-induced capillary leakage and reduces tumour growth in adenocarcinoma-bearing mice. Br. J. Cancer, 73, 189-196.
35. PANES, J., PERRY, M.A., ANDERSON, D.C., MANNING, A., LEONE, B., CEPINSKAS, G., ROSENBLOOM, C.L., MIYASAKA, M., KVIETYS, P.R. & GRANGER, D.N. (1995). Regional differences in constitutive and induced ICAM-1 expression in vivo. Am. J. Physiol., 269, H1955-H1964.
36. PHILIP, P.A. (1998). Interleukin-2 in the treatment of malignant melanoma. Expert. Opin. Invest. Drugs., 7, 361-371.
37. RAZAVI, H.M., WANG LE, F., WEICKER, S., ROHAN, M., LAW, C., MCCORMACK, D.G. & MEHTA, S. (2004). Pulmonary neutrophil infiltration in murine sepsis: role of inducible nitric oxide synthase. Am. J. Respir. Crit. Care Med., 170, 227-233.
38. SATO, Y., VAN EEDEN, S.F., ENGLISH, D. & HOGG, J.C. (1998). Pulmonary sequestration of polymorphonuclear leukocytes released from bone marrow in bacteremic infection. Am. J. Physiol., 275, L255-L261.
39. SATO, Y., WALLEY, K.R., KLUT, M.E., ENGLISH, D., D'YACHKOVA, Y., HOGG, J.C. & VAN EEDEN, S.F. (1999). Nitric oxide reduces the sequestration of polymorphonuclear leukocytes in lung by changing deformability and CD18 expression. Am. J. Respir. Crit. Care Med., 159, 1469-1476.
40. SCHRADER, A.J., HEIDENREICH, A., HEGELE, A., OLBERT, P., OHLMANN, C.H., VARGA, Z., VON KNOBLOCH, R. & HOFMANN, R. (2005). Application of thalidomide/interleukin-2 in immunochemotherapy-refractory metastatic renal cell carcinoma. Anticancer Drugs, 16, 581-585.
41. SECCO, D.D., PARON, J.A., DE OLIVEIRA, S.H., FERREIRA, S.H., SILVA, J.S. & CUNHA FDE, Q. (2003). Neutrophil migration in inflammation: nitric oxide inhibits rolling, adhesion and induces apoptosis. Nitric Oxide, 9, 153-164.
42. SINKOVICS, J.G. & HORVATH, J.C. (2005). Human natural killer cells: a comprehensive review. Int. J. Oncol., 27, 5-47.
43. SMITH, K.A. (2001). To cure chronic HIV infection, a new therapeutic strategy is needed. Curr. Opin. Immunol., 13, 617-624.
44. SNYDMAN, D.R., SULLIVAN, B., GILL, M., GOULD, J.A., PARKINSON, D.R. & ATKINS, M.B. (1990). Nosocomial sepsis associated with interleukin-2. Ann. Intern. Med., 112, 102-107.
45. SOUZA, D.G., CASSALI, G.D., POOLE, S. & TEIXEIRA, M.M. (2001). Effects of inhibition of PDE4 and TNF-alpha on local and remote injuries following ischaemia and reperfusion injury. Br. J. Pharmacol., 134, 985-994.
46. SPIECKER, M., DARIUS, H., KABOTH, K., HUBNER, F. & LIAO, J.K. (1998). Differential regulation of endothelial cell adhesion molecule expression by nitric oxide donors and antioxidants. J. Leukocyte Biol., 63, 732-739.
47. STEVENS, P. & PIAZZA, D.E. (1990). Interleukin-2 increases the oxidative activity and induces migration of murine polymorphonuclear leukocytes in vivo. Int. J. Immunopharmacol., 12, 605-611.
48. TAVARES-MURTA, B.M., CUNHA, F.Q. & FERREIRA, S.H. (1998). The intravenous administration of tumor necrosis factor alpha, interleukin 8 and macrophage-derived neutrophil chemotactic factor inhibits neutrophil migration by stimulating nitric oxide production. Br. J. Pharmacol., 124, 1369-1374.
49. TAVARES-MURTA, B.M., ZAPAROLI, M., FERREIRA, R.B., SILVA-VERGARA, M.L., OLIVEIRA, C.H., MURTA, E.F., FERREIRA, S.H. & CUNHA, F.Q. (2002). Failure of neutrophil chemotactic function in septic patients. Crit. Care Med., 30, 1056-1061.
50. TERAO, S., SHIRAKAWA, T., GODA, K., KAMIDONO, S., FUJISAWA, M. & GOTOH, A. (2005). Recombinant interleukin-2 enhanced the antitumor effect of ADV/RSV-HSV-tk/ACV therapy in a murine bladder cancer model. Anticancer Res., 25, 2757-2760.
51. THEZE, J., ALZARI, P.M. & BERTOGLIO, J. (1996). Interleukin 2 and its receptors: recent advances and new immunological functions. Immunol. Today, 17, 481-486.
52. WALLAYS, G. & CEUPPENS, J.L. (1993). Human T lymphocyte activation by pokeweed mitogen induces production of TNF-alpha and GM-CSF and helper signaling by IL-1 and IL-6 results in IL-2-dependent T cell growth. Eur. Cytokine Network, 4, 269-277.